ZANNES MARIA (President, CEO) received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/14/2024ACC: 0001493152-24-023998
DirectorOfficer· President, CEO
Since Aug 2022
+8.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.30K
Price / share
—
Trade value
—
% of position
4.1%
6/12/2024
201.24K→209.54K
Total
Net shares
+8.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2024 | A · Award | +8.30K | — | — | 4.1% | 201.24K | 209.54K |
| Total | +8.30K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported